Expression of transforming growth factor β1 (TGFβ1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis

Pancreas

Volumn 16, Issue 4, 1998, Pages 468-474

  Satoh, Kennichi ^a   Shimosegawa, Tooru ^a   Hirota, Morihisa ^a   Koizumi, Masaru ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic pancreatitis; Pancreatic carcinoma; Transforming growth factor receptor; Transforming growth factor 1

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL;

EID: 0031957710     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199805000-00002     Document Type: Article

References (32)

1. Halvorsen TB, Seim EVA. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989;42:162-6.
2. Barsky SH, Gopalakrishina R. Increased invasion and spontaneous metastasis of BL 6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res 1987;47:1663-7.
3. Satoh K, Ohtani H, Simosegawa T, Koizumi M, Sawai T, Toyota T. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 1994;107:1488-95.
4. Di Mango EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas, 2nd ed. New York: Raven Press, 1993: 665-706.
5. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Roberts AB, ed. Handbook of experimental pharmacology: peptide growth factors and their receptors I. Berlin: Springer-Verlag, 1990;95:665-706.
6. Lawrence DA, Pircher R, Jullien P. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem Biophys Res Commun 1985;133:1026-34.
7. Van Laethem J-L, Deviere J, Resibois A, et al. Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995;108:1873-81.
8. Slater SD, Williamson RCN, Foster CS. Expression of transforming growth factor-β1 in chronic pancreatitis. Digestion 1995;56: 237-41.
9. Okuda S, Languno LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990;86:453-62.
10. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor β1 with hepatic fibrosis. J Cell Biol 1989;108:2477-82.
11. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991;88:6642-6.
12. Kimchi A, Wang X-F, Weinberg RA, Cheifetz S, Massague J. Absence of TGFβ receptors and growth inhibitory responses in retinoblastoma cells. Science 1988;240:196-8.
13. Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmin A. Loss of growth control by TGF-β occurs at a late stage of mouse skin carcinogenesis and its independent of ras gene activation. Oncogene 1991;6:1465-70.
14. Park K, Kim S-J, Bang Y-J, et al. Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994;91:8772-6.
15. Chapla A, Joan RH, Ellen AR, et al. Transforming growth factor β1 regulation of metalloproteinase production in cultured human cervical cells. Cancer Res 1994;54:943-9.
16. Shimizu S, Nishikawa Y, Kuroda K, Richard LE. Involvement of transforming growth factor β1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 1996;56:3366-70.
17. Friess H, Yamanaka Y, Büchler M, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
18. Chen R, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGFβ activities. Science 1993;260:1335-8.
19. Bassing CH, Yingling JM, Howe DJ, et al. A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994;263:87-9.
20. Baldwin RL, Friess H, Yokoyama M, et al. Attenuated ALK 5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 1996;67:283-8.
21. Friess H, Yamanaka Y, Büchler M, et al. Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor. Cancer Res 1993;53:2704-7.
22. Hermanek P, Sobin LH. UICC TNM classification of malignant tumors, 4th ed., 2nd rev. Berlin: Springer-Verlag, 1992.
23. Klöppel G. Pathology of nonendocrine pancreatic tumors. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Scheele GA, eds. The pancreas, 2nd ed. New York: Raven Press, 1993:871-97.
24. Mizoi T, Ohtani H, Miyazono K, et al. Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stroma cells. Cancer Res 1993;53:183-90.
25. Kai T, Taketazu F, Kawakami M, et al. Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue. Jpn J Cancer Res 1996;87:296-304.
26. Vrana JA, Stang MT, Grande JP, Getz MJ. Expressing of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell derived members of the transforming growth factor β family. Cancer Res 1996;56:5063-70.
27. Schmid P, Itin P, Rufli TH. In situ analysis of transforming growth factors-β (TGF-β1, TGF-β2, TGF-β3) and TGFβ-type II receptor expression in basal cell carcinomas. Br J Dermatol 1996;134: 1044-51.
28. Makowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer with microsatellite instability. Science 1995;268:1336-8.
29. Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP. Mutation analysis of the transforming growth factor type II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem Biophys Res Commun 1996;223:561-4.
30. Frazén P, Ichijo H, Miyazono K. Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res 1993;207:1-7.
31. Satoh K, Sasano H, Shimosegawa T, et al. An immunohistochemical study of the c-erb B-2 oncogene product in intraductal mucinhypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 1993;72:51-6.
32. Satoh K, Shimosegawa T, Koizumi M, Toyota T. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas. Anticancer Res 1997;17:215-20.